6:30–7:45 am
TP200 Breakfast Workshop –Digital Pathology: Making a Difference in Your Practice
Eric F. Glassy MD, FCAP
Eric E. Walk MD, FCAP
TP210 Breakfast Workshop – Genomic Medicine in Pathology Practice
Debra G.B. Leonard, MD, PhD, FCAP
TP220 Breakfast Workshop – Management Tool for Professional Practice Evaluation (OPPE/FPPE)
Keren I. Hulkower, PhD
8:00–9:00 am
CP109 Bioterrorism: Is Your Microbiology Laboratory Prepared? NEW
Elizabeth A. Wagar, MD, FCAP
8:00–11:30 am
AP120 Molecular Hematopathology in the Era of Personalized Medicine
Nathanael G. Bailey, MD, FCAP
Kojo S.J. Elenitoba-Johnson, MD
Megan S. Lim, MD, PhD
AP121 Diffuse Malignant Mesothelioma: Current Diagnostic and Epidemiologic Issues NEW
Timothy C. Allen, MD, JD, FCAP
Alain C. Borczuk, MD, FCAP
AP122 Insights and Controversies in Pulmonary Neoplasia
Philip T. Cagle, MD, FCAP
Sanja Dacic, MD, PhD, FCAP
CP110 Evaluating Myeloid Stem Cell Disorders by Flow Cytometry (AML and Myelodysplasia)
Sindhu Cherian, MDP
Sa Wang, MD, FCAP
ST106 The Visible Pathologist NEW
M. Elizabeth H. Hammond, MD, FCAP
Stephen P. Naber, MD, PhD, FCAP
Thomas M. Wheeler, MD, FCAP
9:30–11:30 am
AP123 Challenges and Pitfalls in Head and Neck Cytopathology NEW
Zubair W. Baloch, MD, PhD, FCAP
William C. Faquin, MD, PhD, FCAP
AP124 At LAST! Standardization of HPV-Related Neoplasia: The CAP-ASCCP Lower Anogenital Squamous Terminology (LAST) Project NEW
Teresa M. Darragh, MD, FCAP
David C. Wilbur, MD, FCAP
PM105 Laboratory Operations During a Disaster: Are You Prepared? NEW
Gina Potenza, MS
Thomas L. Williams, MD, FCAP
ST107 Block and Slide Tracking in Anatomic Pathology as an Essential Element of a Quality and Safety Program
Walter H. Henricks, MD, FCAP
Liron Pantanowitz, MD, FCAP
John H. Sinard, MD, PhD, FCAP
VM111 Selected Topics in Gynecologic Pathology—the Stuff No One Ever Tells You NEW
Debra S. Heller, MD, FCAP
Round Table Discussions—Lunch Included
Noon–1:00 pm
Join the experts for lunch! Exchange information and share solutions in a relaxed setting with your peers.
You will learn to:
• Apply solutions to common problems through interactive
sessions with colleagues
RT107 Forum on Molecular Testing
Rebecca T. Horvat, PhD
RT108 The Pathologist as a Leader
Michael B. Cohen, MD, FCAP
Luke A. Perkocha, MD, MBA, FCAP
RT109 The Current Controversy Regarding Detection and Measurement of Antinuclear Antibodies
Melissa R. Snyder, PhDP
RT110 Direct-to-Consumer Genetic Testing: How Does It Affect Pathologists?
Nazneen Aziz, PhD
2:00-4:00 pm
AP125 Diagnostic Histopathology of Soft Tissue Neoplasms NEW
Markku M. Miettinen, MD
Eduardo V. Zambrano, MD, FCAP
AP126 Small B-Cell Lymphomas: Review of Clinical Implications and Practical Approaches to Appropriate Subclassification NEW
Mehdi Nassiri, MD
Kathryn A. Rizzo, DO, PhD, FCAP
AP127 Molecular Advances in Genito-Urologic Malignancies: Diagnostic and Theranostic Applications
George J. Netto, MD, FCAP
CP111 Antiplatelet Agents and Anticoagulants: Laboratory Monitoring
Michael Laposata, MD, PhD, FCAP
CP112 Drug Testing for Chronic Pain Therapy: How to Interpret the Results and Provide Effective Clinical Consultation
Tai C. Kwong, PhD
Barbarajean Magnani, PhD, MD, FCAP
CP113 Point-of-Care Testing Toolkit—Building a Program, Building a Network
Cynthia L. Foss-Bowman, MD, FCAP
Tim R. Hamill, MD, FCAP
PM106 Building a Culture of Patient Safety: The Role of Pathologist Leadership
Michael B. Cohen, MD, FCAP
Emily E. Volk, MD, FCAP
PM107 The New Interfaces and Accountabilities of the Laboratory Director NEW
Richard E. Horowitz, MD, FCAP
Elizabeth A. Wagar, MD, FCAP
ST108 The Impact of “Meaningful Use” of Electronic Health Records on Your Laboratory
Walter H. Henricks, MD, FCAP
VM112 Common Challenges in the Classification of Interstitial Lung Diseases
Sanja Dacic, MD, PhD, FCAP
6:00 pm